The Foundation awards $67,000 to Pharma Partner/Oregon Health & Science University Pilot Study.
This study examines a new set of cell surface receptors in DIPG to determine whether their co-expression matches a profile consistent with novel biologic targets being developed by a potential pharmaceutical partner.
